ArticleMedicina (Kaunas, Lithuania)2022

Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Thrombolytic Therapy.

Ilga Kikule et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.